Dr. Pantelis Vlachos, Vice President, Customer Success
September 15, 2021
There is recognized heterogeneity within any given tumor‐type from patient to patient (inter‐patient heterogeneity),..
Read article
Esha Senchaudhuri
July 27, 2021
Program and portfolio optimization creates a framework throughout the course of the clinical development journey, that..
Read article
Mansha Sachdev
July 21, 2021
Conducting a transparent, targeted and robust benefit-risk assessment of a new drug or product is one of the most..
Read article
Dr. Pantelis Vlachos, Vice President, Customer Success
July 2, 2021
Popular statistical designs, such as CRM (O’Quigley et al., 1990), mTPI-2 (Guo et al., 2017), and i3+3 (Liu et al.,..
Read article
Mansha Sachdev
June 25, 2021
The main challenge associated with the development of therapies for rare diseases is typically the small study sample..
Read article
Mansha Sachdev
June 4, 2021
Bayesian methods have been playing a key role in transforming clinical research in therapeutic areas such as oncology..
Read article
Mansha Sachdev
June 3, 2021
Bayesian methods allow for the incorporation of prior knowledge, in terms of either expert opinion from clinicians or..
Read article
Dr. Pantelis Vlachos, Vice President, Customer Success
May 28, 2021
Advancements in biomarkers and momentum in precision medicine has paved the foundation for complex studies like basket..
Read article
Mansha Sachdev
May 21, 2021
Most of us are familiar with the concept of platform clinical trials as they have gained popularity in the recent..
Read article
